Neurocrine Biosciences revenue
Neurocrine Biosciences (NBIX) reported revenue of $2.86 B for fiscal year 2025, +21.4% compared with the year before. Over the last 12 months revenue was $3.70 B.
Revenue 2025$2.86 B
Change+21.4%
World rank#844
Market cap$15.85 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $2.86 B | +21.4% |
| 2024 | $2.36 B | +24.8% |
| 2023 | $1.89 B | +26.8% |
| 2022 | $1.49 B | — |
Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.